Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Interest & Investment Income (2021 - 2022)

Coeptis Therapeutics Holdings has reported Interest & Investment Income over the past 2 years, most recently at $257.0 for Q3 2022.

  • Quarterly results put Interest & Investment Income at $257.0 for Q3 2022, up 1506.25% from a year ago — trailing twelve months through Sep 2022 was $8969.0 (changed N/A YoY), and the annual figure for FY2025 was $116495.0, down 50.37%.
  • Interest & Investment Income for Q3 2022 was $257.0 at Coeptis Therapeutics Holdings, up from $49.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for COEPW hit a ceiling of $6753.0 in Q1 2022 and a floor of $16.0 in Q3 2021.